Metformin and Salinomycin as the Best Combination for the Eradication of NSCLC Monolayer Cells and Their Alveospheres (Cancer Stem Cells) Irrespective of EGFR, KRAS, EML4/ALK and LKB1 Status

Oncotarget - United States
doi 10.18632/oncotarget.2657
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

P1.01-05 Metformin in Combination With Crizotinib for the Treatment of EML4-ALK+ Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Fusion of EML4 and ALK Is Associated With Development of Lung Adenocarcinomas Lacking EGFR and KRAS Mutations and Is Correlated With ALK Expression

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2010English

Targeted Photodynamic Therapy as Potential Treatment Modality for the Eradication of Colon Cancer and Colon Cancer Stem Cells

Tumor Biology
MedicineCancer Research
2017English

Clinical Evaluation of the Utility of a Liquid Biopsy (Circulating Tumoral Cells and ctDNA) to Determine the Mutational Profile (EGFR, KRAS, ALK, ROS1 and BRAF) in Advanced NSCLC Patients

Annals of Oncology
MedicineOncologyHematology
2016English

Roles of WNT/Β-Catenin Signaling in the Gastric Cancer Stem Cells Proliferation and Salinomycin Treatment

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2014English

The Biology and Treatment of EML4-ALK Non-Small Cell Lung Cancer

European Journal of Cancer
Cancer ResearchOncology
2010English

Effects of SMYD2-mediated EML4-ALK Methylation on the Signaling Pathway and Growth in Non-Small-Cell Lung Cancer Cells

Cancer Science
Cancer ResearchMedicineOncology
2017English

Stem Cells and Cancer Stem Cells

2011English

P2.13-06 TP53 Status in Relation to Response to Anti-Alk Agents in Patients With EML4-ALK-Translocated NSCLC

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy